Professional

Key Takeaways   Rapid growth in regenerative and alternative therapies is expanding Healthcare Liability exposures across medspas and healthcare providers.   Coverage considerations are multifaceted, with many carriers applying exclusions, limitations, and strict underwriting requirements for non-FDA-approved and off-label treatments.   A complex regulatory environment, driven by both federal and state oversight, impacts how Healthcare Liability risks are evaluated and underwritten  Many claims stem from insufficient informed consent, patient screening, and marketing practices…

Inside This Article:  Wagner SprayTech has recalled more than 700,000 power steamers after receiving at least 156 reports of overheating and hot water release, including more than 50 burn injuries.  The recall comes just weeks after another large-scale steam cleaner recall by Dupray, whose product was linked to 15 reports of boiler ruptures and four injuries.  Consumer bodily injury claims can…

Misleading marketing materials, website content and social media posts can quickly become a significant Healthcare Liability exposure.  In this short clip from our recent webinar on regenerative and alternative therapies, Lily Chetosky, Broker, Professional Liability, Burns & Wilcox, Chicago, Illinois, explains how patient expectations shaped by marketing can lead to costly claims.  https://vimeo.com/1177367526/0dad2278f1?share=copy&fl=sv&fe=ci  

Inadequate patient screening in Telehealth can create significant Healthcare Liability exposure.  In this short clip from our recent webinar on regenerative and alternative therapies, Kelli Bernstein, Inside Broker, Brokerage Division, Burns & Wilcox, Atlanta, Georgia, explains how gaps in screening and evaluation can lead to increased risk and potential claims.  https://vimeo.com/1177366805/c08e5cfc77?share=copy&fl=sv&fe=ci  

Understanding the distinction between product and provider exposure is critical in Healthcare Liability.  In this short clip from our recent webinar on regenerative and alternative therapies, special guest Carrie Roberts, RPLU, Vice President, Professional Brokerage Division, GenStar Insurance Services, explains how these differences influence risk evaluation and coverage. https://vimeo.com/1177361685/71abe58095?fl=ip&fe=ec  

Regenerative and alternative therapies—such as peptides, NAD+, ketamine, and stem cells—are rapidly expanding across healthcare and medspa settings. While these treatments present new opportunities for providers, they also introduce complex Healthcare Liability exposures.  Now available on demand, this webinar features experts from Burns & Wilcox and GenStar Insurance Services as they explore evolving standards of care, regulatory scrutiny, and coverage…

Inside This Article:  A recent Stanford and Harvard study found that medical AI systems generated severe clinical errors in a significant percentage of patient cases.  Many healthcare professionals are using AI tools on the job, with one recent survey finding that almost half of nurses use generative AI at work.  These reports point to an evolving risk landscape for…

Inside This Article:  Federal regulators are claiming that former Lottery.com Inc. executives misled investors by falsely inflating revenues, according to reports.  The Securities and Exchange Commission lawsuit follows guilty pleas by two former executives reportedly involved in a fraudulent $30 million financing deal, Bloomberg Law reported.  Directors & Officers (D&O) Insurance can respond to these types of allegations, though coverage may depend on…